Abstract
We retrospectively assessed breakthrough invasive fungal infections (b-IFIs) in 100 consecutive patients with leukemia receiving single-agent isavuconazole; 13 had documented b-IFIs (candidiasis in 6, mucormycosis in 4). All b-IFIs were observed in patients with prolonged neutropenia and active leukemia.
Original language | English (US) |
---|---|
Pages (from-to) | 1610-1613 |
Number of pages | 4 |
Journal | Clinical Infectious Diseases |
Volume | 67 |
Issue number | 10 |
DOIs | |
State | Published - Oct 30 2018 |
Keywords
- breakthrough
- invasive fungal infections
- isavuconazole
- leukemia
- neutropenia
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases